MLSS MILESTONE SCIENTIFIC

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida.

Mr. Haverhals will present on Thursday, October 21st at 1:10 pm Eastern Time and will also be participating in one-on-one meetings with qualified investors throughout the conference.

The live webcast and subsequent archived recordings for the presentation can be accessed and on the investor relations section of the Milestone Scientific website at .

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SIPC, is a full-service investment bank headquartered in Boca Raton, FL. .

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the or visit .

Contact: David Waldman or Natalya Rudman

Crescendo Communications, LLC

Email:

Tel: 212-671-1020



EN
18/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: October 29, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Milestone Scientific Highlights Operational Progress and Growth Initia...

Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and improved financial performance ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update highlighting the Company’s...

 PRESS RELEASE

Milestone Scientific Commits to Regaining NYSE American Compliance Fol...

Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification Notification has no immediate effect on the Company’s listing or day-to-day operations ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has received a letter (the “Letter”) from NYSE American LLC (the “NYSE American”) dated October 8, 2025, stating that the Company is not in compliance with the continued listing standar...

 PRESS RELEASE

Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors t...

Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional ...

 PRESS RELEASE

Milestone Scientific Achieves 25% Increase in Revenue for the Second Q...

Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 Expands senior leadership team and board of directors to support next phase of growth ROSELAND, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the second quarter ended June 30, 2025. Neal Goldman, Chairman of the Board, stated, “We are pleased with our revenue performance in the second quarter, de...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch